| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Jessica E Kenison, Aditi Jhaveri, Zhaorong Li, Nikita Khadse, Emily Tjon, Sara Tezza, Dominika Nowakowska, Agustin Plasencia, Vincent P Stanton, David H Sherr, Francisco J Quintan. Tolerogenic nanoparticles suppress central nervous system inflammation. Proceedings of the National Academy of Sciences of the United States of America. vol 117. issue 50. 2021-02-01. PMID:33239445. |
nlps loaded with the ahr agonist ite and a t cell epitope from myelin oligodendrocyte glycoprotein (mog) |
2021-02-01 |
2023-08-13 |
Not clear |
| Helen Cross, Farahna Sabiq, Nathalie Ackermans, Andrew Mattar, Shelly Au, Mark Woodhall, Bo Sun, Virginia Devonshire, Robert Carruthers, Ana Luiza Sayao, Virender Bhan, Alice Schabas, Jillian Chan, Marvin Fritzler, Patrick Waters, Anthony Traboulse. Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Positive Patients in a Multi-Ethnic Canadian Cohort. Frontiers in neurology. vol 11. 2021-01-30. PMID:33510701. |
myelin oligodendrocyte glycoprotein (mog) antibody positive patients in a multi-ethnic canadian cohort. |
2021-01-30 |
2023-08-13 |
Not clear |
| Kazuo Fujihara, Lawrence J Coo. Neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody-associated disease: current topics. Current opinion in neurology. vol 33. issue 3. 2021-01-28. PMID:32374571. |
we reviewed present topics on neuromyelitis optica spectrum disorders (nmosd) and myelin oligodendrocyte glycoprotein (mog)-antibody-associated disease (mogad). |
2021-01-28 |
2023-08-13 |
Not clear |
| Jagannadha Avasarala, Creed Pettigrew, Paige Sutton, Zain Guduru, Julie Gurwell, Brent S Sokola, Selina Mullin. Can a diagnosis of multiple sclerosis be made without ruling out neuromyelitis optica spectrum disorder ? Multiple sclerosis and related disorders. vol 40. 2021-01-25. PMID:31986427. |
although testing is available for aquaporin 4 (aqp4) and myelin oligodendrocyte glycoprotein (mog) antibodies, screening for nmosd is recommended but not mandatory to establish a diagnosis of ms. |
2021-01-25 |
2023-08-13 |
Not clear |
| Susanna Asseyer, Josh Hamblin, Silvia Messina, Romina Mariano, Nadja Siebert, Rosie Everett, Wilhelm Küker, Judith Bellmann-Strobl, Klemens Ruprecht, Sven Jarius, Maria Isabel Leite, Alexander U Brandt, Friedemann Paul, Jacqueline Palac. Prodromal headache in MOG-antibody positive optic neuritis. Multiple sclerosis and related disorders. vol 40. 2021-01-25. PMID:32062443. |
myelin oligodendrocyte glycoprotein antibody (mog-ab) disease is an inflammatory autoimmune condition of the central nervous system, defined by antibodies (abs) against mog. |
2021-01-25 |
2023-08-13 |
Not clear |
| John J Chen, M Tariq Bhatt. Clinical phenotype, radiological features, and treatment of myelin oligodendrocyte glycoprotein-immunoglobulin G (MOG-IgG) optic neuritis. Current opinion in neurology. vol 33. issue 1. 2021-01-22. PMID:31743235. |
to review the clinical characteristics, radiological manifestations and treatment of myelin oligodendrocyte glycoprotein (mog)-immunoglobulin g (igg) optic neuritis. |
2021-01-22 |
2023-08-13 |
Not clear |
| Liming Cao, Lijie Ren, Xuming Huan. Clinical analysis of a patient simultaneously positive for antibodies of myelin oligodendrocyte glycoprotein and anti-N-methyl-D-aspartate receptor: A case report. Medicine. vol 100. issue 1. 2021-01-22. PMID:33429822. |
myelin oligodendrocyte glycoprotein (mog) antibody (mog-ab) disease (mog-ad) is a type of demyelinating disease of the central nervous system characterized by a high frequency of optic neuritis (on) attacks. |
2021-01-22 |
2023-08-13 |
Not clear |
| Dangfeng Zhang, Lin Qiao, Ting F. Paricalcitol improves experimental autoimmune encephalomyelitis (EAE) by suppressing inflammation via NF-κB signaling. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. vol 125. 2021-01-19. PMID:32106388. |
here, the c57bl/6 mice were immunized using myelin oligodendrocyte glycoprotein 35-55 (mog |
2021-01-19 |
2023-08-13 |
mouse |
| Bert A 't Har. A Tolerogenic Role of Cathepsin G in a Primate Model of Multiple Sclerosis: Abrogation by Epstein-Barr Virus Infection. Archivum immunologiae et therapiae experimentalis. vol 68. issue 4. 2021-01-19. PMID:32556812. |
it is discussed here that b cells prevent the activation of strongly pathogenic t cells present in the naïve repertoire, which are directed against the immunodominant myelin antigen mog (myelin oligodendrocyte glycoprotein). |
2021-01-19 |
2023-08-13 |
Not clear |
| Mitsugu Yanagidaira, Takaaki Hattori, Hirofumi Emoto, Motohiro Kiyosawa, Takanori Yokot. Optic perineuritis with anti-myelin oligodendrocyte glycoprotein antibody. Multiple sclerosis and related disorders. vol 38. 2021-01-18. PMID:31711001. |
anti-myelin oligodendrocyte glycoprotein (mog) antibody was positive in both serum and cerebrospinal fluid. |
2021-01-18 |
2023-08-13 |
Not clear |
| Jonas Graf, Jan Mares, Michael Barnett, Orhan Aktas, Philipp Albrecht, Scott S Zamvil, Hans-Peter Hartun. Targeting B cells to modify MS, NMOSD, and MOGAD: Part 2. Neurology(R) neuroimmunology & neuroinflammation. vol 8. issue 1. 2021-01-13. PMID:33411674. |
this part of the review focuses on monoclonal antibody b cell-depleting strategies in nmosd and the emerging related myelin oligodendrocyte glycoprotein (mog) immunoglobulin g-associated disease (mogad). |
2021-01-13 |
2023-08-13 |
Not clear |
| A Cerveró, M J Sedano-Tous, J Madera, A López-de-Eguileta, A Casad. Use of ganglion cell layer analysis for diagnosing anti-glycoprotein neuromyelitis optica of oligodendrocyte myelin. Archivos de la Sociedad Espanola de Oftalmologia. vol 95. issue 3. 2020-12-31. PMID:31980323. |
althogh the anti-myelin oligodendrocyte glycoprotein (mog) and anti-aqp4 (aquaporin-4) antibodies were negative at first, bilateral involvement of the ganglion cells suggested an extensive lesion that is more characteristic of seropositive anti-mog neuromyelitis. |
2020-12-31 |
2023-08-13 |
Not clear |
| Zhong Zhang, Jian Wang, Zongbin Song, Yunjiao Wang, Zhigang Cheng, Qulian Guo, E Wang, Yanping Jian, Lei W. Downregulation of microRNA-199a-5p alleviated lidocaine-induced sensory dysfunction and spinal cord myelin lesions in a rat model. Toxicology letters. vol 336. 2020-12-31. PMID:33166664. |
myrf and its downstream factors myelin basic protein (mbp), proteolipid protein (plp) and myelin oligodendrocyte glycoprotein (mog) were significantly decreased after intrathecal 10 % lidocaine administration. |
2020-12-31 |
2023-08-13 |
rat |
| Tuancheng Feng, Rory R Sheng, Santiago Solé-Domènech, Mohammed Ullah, Xiaolai Zhou, Christina S Mendoza, Laura Camila Martinez Enriquez, Isabel Iscol Katz, Daniel H Paushter, Peter M Sullivan, Xiaochun Wu, Frederick R Maxfield, Fenghua H. A role of the frontotemporal lobar degeneration risk factor TMEM106B in myelination. Brain : a journal of neurology. vol 143. issue 7. 2020-12-30. PMID:32572497. |
tmem106b deficiency in mice results in myelination defects with a significant reduction of protein levels of proteolipid protein (plp) and myelin oligodendrocyte glycoprotein (mog), the membrane proteins found in the myelin sheath. |
2020-12-30 |
2023-08-13 |
mouse |
| Mohamed B Hassan, Caroline Stern, Eoin P Flanagan, Sean J Pittock, Amy Kunchok, Robert C Foster, Jiraporn Jitprapaikulsan, David O Hodge, M Tariq Bhatti, John J Che. Population-Based Incidence of Optic Neuritis in the Era of Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibodies. American journal of ophthalmology. vol 220. 2020-12-22. PMID:32707199. |
to re-evaluate the population-based incidence of optic neuritis in the era of aquaporin-4-immunoglobulin g (aqp4-igg) and myelin oligodendrocyte glycoprotein (mog)-igg, which are biomarkers of optic neuritis that is distinct from multiple sclerosis (ms). |
2020-12-22 |
2023-08-13 |
Not clear |
| R Michael E Parkhouse, Edda Sciutto, Marisela Hernández, Maria M Cortez, Arturo Carpio, Agnès Fleur. Extraparenchymal human neurocysticercosis induces autoantibodies against brain tubulin and MOG35-55 in cerebral spinal fluid. Journal of neuroimmunology. vol 349. 2020-12-16. PMID:32977250. |
using elisa methodology, we demonstrate autoantibodies to tubulin and the major oligodendrocyte glycoprotein (mog) in the csf of most, but not all, ep-nc samples. |
2020-12-16 |
2023-08-13 |
human |
| Yoshiki Takai, Tatsuro Misu, Kimihiko Kaneko, Norio Chihara, Koichi Narikawa, Satoko Tsuchida, Hiroya Nishida, Takashi Komori, Morinobu Seki, Teppei Komatsu, Kiyotaka Nakamagoe, Toshimasa Ikeda, Mari Yoshida, Toshiyuki Takahashi, Hirohiko Ono, Shuhei Nishiyama, Hiroshi Kuroda, Ichiro Nakashima, Hiroyoshi Suzuki, Monika Bradl, Hans Lassmann, Kazuo Fujihara, Masashi Aok. Myelin oligodendrocyte glycoprotein antibody-associated disease: an immunopathological study. Brain : a journal of neurology. vol 143. issue 5. 2020-12-14. PMID:32412053. |
conformation-sensitive antibodies against myelin oligodendrocyte glycoprotein (mog) are detectable in patients with optic neuritis, myelitis, opticomyelitis, acute or multiphasic disseminated encephalomyelitis (adem/mdem) and brainstem/cerebral cortical encephalitis, but are rarely detected in patients with prototypic multiple sclerosis. |
2020-12-14 |
2023-08-13 |
Not clear |
| Kumaran Deiva, Alvaro Cobo-Calvo, Hélène Maurey, Alienor De Chalus, Elise Yazbeck, Béatrice Husson, Sandra Vukusic, Che Serguerra, Philippe Horellou, Romain Marignie. Risk factors for academic difficulties in children with myelin oligodendrocyte glycoprotein antibody-associated acute demyelinating syndromes. Developmental medicine and child neurology. vol 62. issue 9. 2020-12-14. PMID:32567093. |
to describe cognitive abilities through the evaluation of academic difficulties in children with acute demyelinating syndromes (ads) and myelin oligodendrocyte glycoprotein (mog) antibodies. |
2020-12-14 |
2023-08-13 |
Not clear |
| Alexander W Boyden, Ashley A Brate, Nitin J Karandika. Novel B cell-dependent multiple sclerosis model using extracellular domains of myelin proteolipid protein. Scientific reports. vol 10. issue 1. 2020-12-10. PMID:32193439. |
dissecting the function of b cells in the ms mouse model experimental autoimmune encephalomyelitis (eae) is largely confined to induction with either the myelin oligodendrocyte glycoprotein epitope mog |
2020-12-10 |
2023-08-13 |
mouse |
| Xinran Maria Xiang, Rachel Evans, Jesus Lovera, Rashmi Ra. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease Presenting as Recurrent and Migrating Focal Cortical Encephalitis. Child neurology open. vol 7. 2020-11-27. PMID:33241072. |
although pediatric myelin oligodendrocyte glycoprotein (mog) antibody-associated disease is increasingly well-recognized, its full clinical spectrum is still being defined. |
2020-11-27 |
2023-08-13 |
Not clear |